Global Pneumonia Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 03-Oct-2022
No. of pages: 113
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pneumonia Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Pneumonia Testing market. Further, it explains the major drivers and regional dynamics of the global Pneumonia Testing market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott Molecular

- Fast-track diagnostics

- Becton, Dickenson and Company (BD)

- Roche Molecular Diagnostics

- Thermo Fisher Scientific

- AdvanDx

- Abbott

- Beckman Coulter

- Bio-Rad

- Cepheid

- Concile

- Diamedix

- DiaSorin

- Eiken Chemical

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Pneumonia Testing Segment by Type

- Consumables

- Analyzers

Pneumonia Testing Segment by Application

- Hospital

- Clinic

- Medical Center

- Other

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pneumonia Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Pneumonia Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Pneumonia Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pneumonia Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumonia Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Pneumonia Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Pneumonia Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Molecular, Fast-track diagnostics, Becton, Dickenson and Company (BD), Roche Molecular Diagnostics, Thermo Fisher Scientific, AdvanDx, Abbott, Beckman Coulter and Bio-Rad, etc.

Global Pneumonia Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Consumables
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global Pneumonia Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pneumonia Testing Market Size (2017-2028)
2.2 Pneumonia Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Pneumonia Testing Market Size by Region (2017-2022)
2.4 Global Pneumonia Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Pneumonia Testing Countries Ranking by Market Size
3 Pneumonia Testing Competitive by Company
3.1 Global Pneumonia Testing Revenue by Players
3.1.1 Global Pneumonia Testing Revenue by Players (2017-2022)
3.1.2 Global Pneumonia Testing Market Share by Players (2017-2022)
3.2 Global Pneumonia Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Pneumonia Testing Revenue
3.4 Global Pneumonia Testing Market Concentration Ratio
3.4.1 Global Pneumonia Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Testing Revenue in 2021
3.5 Global Pneumonia Testing Key Players Head office and Area Served
3.6 Key Players Pneumonia Testing Product Solution and Service
3.7 Date of Enter into Pneumonia Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pneumonia Testing Breakdown Data by Type
4.1 Global Pneumonia Testing Historic Revenue by Type (2017-2022)
4.2 Global Pneumonia Testing Forecasted Revenue by Type (2023-2028)
5 Global Pneumonia Testing Breakdown Data by Application
5.1 Global Pneumonia Testing Historic Market Size by Application (2017-2022)
5.2 Global Pneumonia Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pneumonia Testing Revenue by Company (2020-2022)
6.2 North America Pneumonia Testing Revenue by Type (2017-2028)
6.3 North America Pneumonia Testing Revenue by Application (2017-2028)
6.4 North America Pneumonia Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Pneumonia Testing Revenue by Company (2020-2022)
7.2 Europe Pneumonia Testing Revenue by Type (2017-2028)
7.3 Europe Pneumonia Testing Revenue by Application (2017-2028)
7.4 Europe Pneumonia Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumonia Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Pneumonia Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Pneumonia Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Pneumonia Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Pneumonia Testing Revenue by Company (2020-2022)
9.2 Latin America Pneumonia Testing Revenue by Type (2017-2028)
9.3 Latin America Pneumonia Testing Revenue by Application (2017-2028)
9.4 Latin America Pneumonia Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumonia Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Pneumonia Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Pneumonia Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Pneumonia Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott Molecular
11.1.1 Abbott Molecular Company Details
11.1.2 Abbott Molecular Business Overview
11.1.3 Abbott Molecular Pneumonia Testing Products and Services
11.1.4 Abbott Molecular Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.1.5 Abbott Molecular Pneumonia Testing SWOT Analysis
11.1.6 Abbott Molecular Recent Developments
11.2 Fast-track diagnostics
11.2.1 Fast-track diagnostics Company Details
11.2.2 Fast-track diagnostics Business Overview
11.2.3 Fast-track diagnostics Pneumonia Testing Products and Services
11.2.4 Fast-track diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.2.5 Fast-track diagnostics Pneumonia Testing SWOT Analysis
11.2.6 Fast-track diagnostics Recent Developments
11.3 Becton, Dickenson and Company (BD)
11.3.1 Becton, Dickenson and Company (BD) Company Details
11.3.2 Becton, Dickenson and Company (BD) Business Overview
11.3.3 Becton, Dickenson and Company (BD) Pneumonia Testing Products and Services
11.3.4 Becton, Dickenson and Company (BD) Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.3.5 Becton, Dickenson and Company (BD) Pneumonia Testing SWOT Analysis
11.3.6 Becton, Dickenson and Company (BD) Recent Developments
11.4 Roche Molecular Diagnostics
11.4.1 Roche Molecular Diagnostics Company Details
11.4.2 Roche Molecular Diagnostics Business Overview
11.4.3 Roche Molecular Diagnostics Pneumonia Testing Products and Services
11.4.4 Roche Molecular Diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.4.5 Roche Molecular Diagnostics Pneumonia Testing SWOT Analysis
11.4.6 Roche Molecular Diagnostics Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Pneumonia Testing Products and Services
11.5.4 Thermo Fisher Scientific Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.5.5 Thermo Fisher Scientific Pneumonia Testing SWOT Analysis
11.5.6 Thermo Fisher Scientific Recent Developments
11.6 AdvanDx
11.6.1 AdvanDx Company Details
11.6.2 AdvanDx Business Overview
11.6.3 AdvanDx Pneumonia Testing Products and Services
11.6.4 AdvanDx Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.6.5 AdvanDx Pneumonia Testing SWOT Analysis
11.6.6 AdvanDx Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Pneumonia Testing Products and Services
11.7.4 Abbott Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.7.5 Abbott Pneumonia Testing SWOT Analysis
11.7.6 Abbott Recent Developments
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Pneumonia Testing Products and Services
11.8.4 Beckman Coulter Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.8.5 Beckman Coulter Pneumonia Testing SWOT Analysis
11.8.6 Beckman Coulter Recent Developments
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Pneumonia Testing Products and Services
11.9.4 Bio-Rad Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.9.5 Bio-Rad Pneumonia Testing SWOT Analysis
11.9.6 Bio-Rad Recent Developments
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Pneumonia Testing Products and Services
11.10.4 Cepheid Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.10.5 Cepheid Pneumonia Testing SWOT Analysis
11.10.6 Cepheid Recent Developments
11.11 Concile
11.11.1 Concile Company Details
11.11.2 Concile Business Overview
11.11.3 Concile Pneumonia Testing Products and Services
11.11.4 Concile Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.11.5 Concile Recent Developments
11.12 Diamedix
11.12.1 Diamedix Company Details
11.12.2 Diamedix Business Overview
11.12.3 Diamedix Pneumonia Testing Products and Services
11.12.4 Diamedix Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.12.5 Diamedix Recent Developments
11.13 DiaSorin
11.13.1 DiaSorin Company Details
11.13.2 DiaSorin Business Overview
11.13.3 DiaSorin Pneumonia Testing Products and Services
11.13.4 DiaSorin Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.13.5 DiaSorin Recent Developments
11.14 Eiken Chemical
11.14.1 Eiken Chemical Company Details
11.14.2 Eiken Chemical Business Overview
11.14.3 Eiken Chemical Pneumonia Testing Products and Services
11.14.4 Eiken Chemical Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.14.5 Eiken Chemical Recent Developments
12 Pneumonia Testing Market Dynamics
12.1 Pneumonia Testing Market Trends
12.2 Pneumonia Testing Market Drivers
12.3 Pneumonia Testing Market Challenges
12.4 Pneumonia Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Pneumonia Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Consumables
Table 3. Key Players of Analyzers
Table 4. Global Pneumonia Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Pneumonia Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Pneumonia Testing Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Pneumonia Testing Revenue Market Share by Region (2017-2022)
Table 8. Global Pneumonia Testing Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Pneumonia Testing Market Share by Players (2017-2022)
Table 10. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Testing as of 2021)
Table 11. Ranking of Global Top Pneumonia Testing Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Pneumonia Testing Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Pneumonia Testing Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Pneumonia Testing Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Pneumonia Testing Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Pneumonia Testing Revenue Market Share by Type (2017-2022)
Table 19. Global Pneumonia Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Pneumonia Testing Revenue Market Share by Type (2023-2028)
Table 21. Global Pneumonia Testing Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Pneumonia Testing Revenue Market Share by Application (2017-2022)
Table 23. Global Pneumonia Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Pneumonia Testing Revenue Market Share by Application (2023-2028)
Table 25. North America Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Pneumonia Testing Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Pneumonia Testing Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 60. Abbott Molecular Company Details
Table 61. Abbott Molecular Business Overview
Table 62. Abbott Molecular Pneumonia Testing Product and Services
Table 63. Abbott Molecular Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 64. Abbott Molecular Pneumonia Testing SWOT Analysis
Table 65. Abbott Molecular Recent Developments
Table 66. Fast-track diagnostics Company Details
Table 67. Fast-track diagnostics Business Overview
Table 68. Fast-track diagnostics Pneumonia Testing Product and Services
Table 69. Fast-track diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 70. Fast-track diagnostics Pneumonia Testing SWOT Analysis
Table 71. Fast-track diagnostics Recent Developments
Table 72. Becton, Dickenson and Company (BD) Company Details
Table 73. Becton, Dickenson and Company (BD) Business Overview
Table 74. Becton, Dickenson and Company (BD) Pneumonia Testing Product and Services
Table 75. Becton, Dickenson and Company (BD) Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickenson and Company (BD) Pneumonia Testing SWOT Analysis
Table 77. Becton, Dickenson and Company (BD) Recent Developments
Table 78. Roche Molecular Diagnostics Company Details
Table 79. Roche Molecular Diagnostics Business Overview
Table 80. Roche Molecular Diagnostics Pneumonia Testing Product and Services
Table 81. Roche Molecular Diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 82. Roche Molecular Diagnostics Pneumonia Testing SWOT Analysis
Table 83. Roche Molecular Diagnostics Recent Developments
Table 84. Thermo Fisher Scientific Company Details
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific Pneumonia Testing Product and Services
Table 87. Thermo Fisher Scientific Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 88. Thermo Fisher Scientific Pneumonia Testing SWOT Analysis
Table 89. Thermo Fisher Scientific Recent Developments
Table 90. AdvanDx Company Details
Table 91. AdvanDx Business Overview
Table 92. AdvanDx Pneumonia Testing Product and Services
Table 93. AdvanDx Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 94. AdvanDx Pneumonia Testing SWOT Analysis
Table 95. AdvanDx Recent Developments
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Pneumonia Testing Product and Services
Table 99. Abbott Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 100. Abbott Pneumonia Testing SWOT Analysis
Table 101. Abbott Recent Developments
Table 102. Beckman Coulter Company Details
Table 103. Beckman Coulter Business Overview
Table 104. Beckman Coulter Pneumonia Testing Product and Services
Table 105. Beckman Coulter Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 106. Beckman Coulter Pneumonia Testing SWOT Analysis
Table 107. Beckman Coulter Recent Developments
Table 108. Bio-Rad Company Details
Table 109. Bio-Rad Business Overview
Table 110. Bio-Rad Pneumonia Testing Product and Services
Table 111. Bio-Rad Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 112. Bio-Rad Pneumonia Testing SWOT Analysis
Table 113. Bio-Rad Recent Developments
Table 114. Cepheid Company Details
Table 115. Cepheid Business Overview
Table 116. Cepheid Pneumonia Testing Product and Services
Table 117. Cepheid Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 118. Cepheid Pneumonia Testing SWOT Analysis
Table 119. Cepheid Recent Developments
Table 120. Concile Company Details
Table 121. Concile Business Overview
Table 122. Concile Pneumonia Testing Product and Services
Table 123. Concile Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 124. Concile Recent Developments
Table 125. Diamedix Company Details
Table 126. Diamedix Business Overview
Table 127. Diamedix Pneumonia Testing Product and Services
Table 128. Diamedix Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 129. Diamedix Recent Developments
Table 130. DiaSorin Company Details
Table 131. DiaSorin Business Overview
Table 132. DiaSorin Pneumonia Testing Product and Services
Table 133. DiaSorin Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 134. DiaSorin Recent Developments
Table 135. Eiken Chemical Company Details
Table 136. Eiken Chemical Business Overview
Table 137. Eiken Chemical Pneumonia Testing Product and Services
Table 138. Eiken Chemical Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 139. Eiken Chemical Recent Developments
Table 140. Pneumonia Testing Market Trends
Table 141. Pneumonia Testing Market Drivers
Table 142. Pneumonia Testing Market Challenges
Table 143. Pneumonia Testing Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Consumables Features
Figure 3. Analyzers Features
Figure 4. Global Pneumonia Testing Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Medical Center Case Studies
Figure 8. Other Case Studies
Figure 9. Pneumonia Testing Report Years Considered
Figure 10. Global Pneumonia Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Pneumonia Testing Market Size 2017-2028 (US$ Million)
Figure 12. Global Pneumonia Testing Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Pneumonia Testing Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Pneumonia Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Pneumonia Testing Market Share by Players in 2021
Figure 16. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Pneumonia Testing Revenue in 2021
Figure 18. North America Pneumonia Testing Revenue Market Share by Company in 2021
Figure 19. North America Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 20. North America Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 21. North America Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 22. U.S. Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Pneumonia Testing Revenue Market Share by Company in 2021
Figure 25. Europe Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 26. Europe Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 27. Europe Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 28. Germany Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 29. France Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Pneumonia Testing Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Pneumonia Testing Revenue Share by Region (2017-2028)
Figure 37. China Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 40. India Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Pneumonia Testing Revenue Market Share by Company in 2021
Figure 49. Latin America Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 52. Mexico Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Pneumonia Testing Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 59. Turkey Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 62. Abbott Molecular Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 63. Fast-track diagnostics Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 64. Becton, Dickenson and Company (BD) Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 65. Roche Molecular Diagnostics Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 67. AdvanDx Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 68. Abbott Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 69. Beckman Coulter Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 70. Bio-Rad Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 71. Cepheid Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 72. Concile Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 73. Diamedix Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 74. DiaSorin Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 75. Eiken Chemical Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
  • Infectious Disease Diagnostics Market by Product & Service (Reagents, Kits), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (Immunodiagnostics, NGS, PCR, ISH, INAAT), Disease (Hepatitis, HIV, HAI, HPV, Syphilis, TB, Flu) - Global Forecast to 2028
    Published: 10-Jan-2024        Price: US 4950 Onwards        Pages: 309
    “Rising focus on decentralized diagnostics is driving the overall growth of the infectious disease diagnostics market.” The infectious disease diagnostics market is valued at an estimated USD 21.4 billion in 2023 and is projected to reach USD 31.5 billion by 2028 at a CAGR of 8.0% during the forecast period. The rising focus on decentralized diagnostics and the growing demand for CLIA-waived PoC tests have driven the use of PoC technologies. The trend towa......
  • Global Pharmaceutical Testing Services Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 102
    Pharmaceutical Testing Service is often used to identify The chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical's solubility and can predict The medication's ability to reach a specific target within The body. Testing may even reveal contamination in The manufacturing production process or highlight other,......
  • Global Pharmaceutical Testing Services Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Pharmaceutical Testing Services market size was valued at US$ 3398.6 million in 2023. With growing demand in downstream market, the Pharmaceutical Testing Services is forecast to a readjusted size of US$ 7008.4 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Pharmaceutical Testing Services market. Pharmaceutical Testing Services are expected to show ......
  • Global Helicobacter Pylori Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Helicobacter Pylori Diagnostics market size was valued at US$ 624.1 million in 2023. With growing demand in downstream market, the Helicobacter Pylori Diagnostics is forecast to a readjusted size of US$ 1040.4 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Helicobacter Pylori Diagnostics market. Helicobacter Pylori Diagnostics are expected to show st......
  • Global Laboratory-developed Testing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Laboratory-developed Testing market size was valued at US$ 3442.2 million in 2023. With growing demand in downstream market, the Laboratory-developed Testing is forecast to a readjusted size of US$ 4512 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Laboratory-developed Testing market. Laboratory-developed Testing are expected to show stable growth i......
  • Global Laboratory-developed Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 109
    According to our (Global Info Research) latest study, the global Laboratory-developed Testing market size was valued at USD 3620.6 million in 2023 and is forecast to a readjusted size of USD 4649.1 million by 2030 with a CAGR of 3.6% during review period. Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vit......
  • Global Pharmaceutical Testing Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 151
    According to our (Global Info Research) latest study, the global Pharmaceutical Testing Services market size was valued at USD 3574.8 million in 2023 and is forecast to a readjusted size of USD 6987.8 million by 2030 with a CAGR of 10.0% during review period. Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication. This knowledge provides insight into a drug's performance and s......
  • Global TB Diagnostic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global TB Diagnostic market: According to our latest research, the global TB Diagnostic market looks promising in the next 5 years. As of 2022, the global TB Diagnostic market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global TB Diagnostic market, with a sys......
  • IVD Products - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 124
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for IVD Products, with both quantitative a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs